Clinical trial
Interventional, open-label, flexible-dose extension study of brexpiprazole in patients with schizophrenia
The primary objective is to evaluate long-term safety and tolerability of brexpiprazole
| Category | Value |
|---|---|
| Study start date | 2013-01-30 |